<p>Xanthogranulomatous epithelial tumour (XGET) is a recently described, rare mesenchymal neoplasm characterized by a <i>HMGA2::NCOR2</i> gene fusion. We report a case of primary intraosseous XGET in the calcaneus of a 32-year-old female presenting with a 10-month history of heel pain. Initial differential diagnosis based on imaging features of the lytic calcaneal lesion included giant cell tumour of bone (GCTB) and solid aneurysmal bone cyst (sABC). Histopathology revealed a bland&#xa0;appearing lesion with xanthomatous histiocytes and giant cells, but immunohistochemistry showed diffuse cytokeratin positivity. Definitive diagnosis was established via molecular confirmation of the <i>HMGA2::NCOR2</i> fusion and absence of <i>H3F3A</i> and <i>USP6</i> alterations. This case documents the radiological features of a rare entity that mimics common bone tumours and emphasizes the role of molecular pathology in distinguishing XGET from other more frequent giant cell-rich lesions.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Xanthogranulomatous epithelial tumour of the calcaneus in a 32-year-old female: a rare entity

  • Darshana Sanghvi,
  • Amrit Kaur Kaler,
  • Manit Gundavda,
  • Shalaka Satpute,
  • Kunal Nadgouda,
  • Nevitha Athikari

摘要

Xanthogranulomatous epithelial tumour (XGET) is a recently described, rare mesenchymal neoplasm characterized by a HMGA2::NCOR2 gene fusion. We report a case of primary intraosseous XGET in the calcaneus of a 32-year-old female presenting with a 10-month history of heel pain. Initial differential diagnosis based on imaging features of the lytic calcaneal lesion included giant cell tumour of bone (GCTB) and solid aneurysmal bone cyst (sABC). Histopathology revealed a bland appearing lesion with xanthomatous histiocytes and giant cells, but immunohistochemistry showed diffuse cytokeratin positivity. Definitive diagnosis was established via molecular confirmation of the HMGA2::NCOR2 fusion and absence of H3F3A and USP6 alterations. This case documents the radiological features of a rare entity that mimics common bone tumours and emphasizes the role of molecular pathology in distinguishing XGET from other more frequent giant cell-rich lesions.